Matthew Vincent Dolan, EVP Strategy & Corp Dev: Dexcom DXCM Sell · Filed 24/03/19

Trade details

Type: Insider sale
Amount: $243,633.48
Shares · price: 1,886 sh · $129.18 a share
Held after: 46,684 sh
Stock: Dexcom DXCM
Person: Matthew Vincent DolanEVP Strategy & Corp Dev
Trade date: 24/03/15
Filed: 24/03/19
Days to filing: 4 days

Sold 3.9% of holdings

Share of holding sold: 3.9%

Dexcom trades, last 26 weeks

What else happened in Dexcom around then

Filed or reported within 30 days of the trade day · 24/02/14~24/04/14

Matthew Vincent Dolan's recent trades

Matthew Vincent DolanEVP, Strategy & Corporate Dev
SellDexcom
Sell
Dexcom
DXCM
$102.8K
1,183 sh
$102.8K
Filed 25/01/30
Traded 25/01/29
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$306.7K
2,423 sh
$306.7K
Filed 24/05/16
Traded 24/05/15
Matthew Vincent DolanEVP Strategy and Corporate Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$274.2K
1,990 sh
$274.2K
Filed 24/04/16
Traded 24/04/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$171.8K
1,314 sh
$171.8K
Filed 24/03/19
Traded 24/03/15
Matthew Vincent DolanEVP Strategy & Corp Dev
Sell10b5-1 planDexcom
Sell10b5-1 plan
Dexcom
DXCM
$131.8K
1,003 sh
$131.8K
Filed 24/03/19
Traded 24/03/15

Matthew Vincent Dolan, EVP — sold $243.6K of Dexcom DXCM · 3.9% of holdings · 10b5-1 plan | Whalegun